These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 16945056)
1. Expanding knowledge in atrial fibrillation, blood pressure treatment, and management of coronary and peripheral artery disease. Crea F Eur Heart J; 2024 Aug; 45(31):2795-2799. PubMed ID: 39150995 [No Abstract] [Full Text] [Related]
2. A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation. Kuntz JL; Schneider JL; Firemark AJ; Dickerson JF; Papajorgji-Taylor D; Reese KR; Hamer TA; Marsh D; Thorsness LA; Sullivan MD; Debar LL; Smith DH Perm J; 2020; 24():. PubMed ID: 33196429 [TBL] [Abstract][Full Text] [Related]
3. "Pharming out" support: a promising approach to integrating clinical pharmacists into established primary care medical home practices. Brunisholz KD; Olson J; Anderson JW; Hays E; Tilbury PM; Winter B; Rickard J; Hamilton S; Parkin G J Int Med Res; 2018 Jan; 46(1):234-248. PubMed ID: 28789606 [TBL] [Abstract][Full Text] [Related]
4. Comparative health systems research among Kaiser Permanente and other integrated delivery systems: a systematic literature review. Maeda JL; Lee KM; Horberg M Perm J; 2014; 18(3):66-77. PubMed ID: 24937150 [TBL] [Abstract][Full Text] [Related]
5. The impact of pharmaceutical care on patients with hypertension and their pharmacists. Skowron A; Polak S; Brandys J Pharm Pract (Granada); 2011 Apr; 9(2):110-5. PubMed ID: 24688618 [TBL] [Abstract][Full Text] [Related]
6. A collaborative cardiologist-pharmacist care model to improve hypertension management in patients with or at high risk for cardiovascular disease. Irons BK; Meyerrose G; Laguardia S; Hazel K; Seifert CF Pharm Pract (Granada); 2012 Jan; 10(1):25-32. PubMed ID: 24155813 [TBL] [Abstract][Full Text] [Related]
7. Behind-the-counter statins: a silver bullet for reducing costs and increasing access? Sood N; Sun E; Zhuo X Health Serv Res; 2012 Feb; 47(1 Pt 1):174-87. PubMed ID: 22091792 [TBL] [Abstract][Full Text] [Related]
8. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related]
9. Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients. St Peter WL; Farley TM; Carter BL Curr Opin Nephrol Hypertens; 2011 Sep; 20(5):498-503. PubMed ID: 21709550 [TBL] [Abstract][Full Text] [Related]
12. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL). Tytus RH; Burgess ED; Assouline L; Vanjaka A Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822 [TBL] [Abstract][Full Text] [Related]
13. [Reasons for not intensifying antihypertensive treatment to diabetes in some regions of China]. Guo QH; Pan CY; Qi WH; Lin SY; Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):240-4. PubMed ID: 18361834 [TBL] [Abstract][Full Text] [Related]
14. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]